Alzheimers Disease Drug Development Program (U01)

The summary for the Alzheimers Disease Drug Development Program (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Alzheimers Disease Drug Development Program (U01)
	CFDA Number:	93.866
	CFDA Description:	Aging Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-10-205
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	May 21, 2010
	Creation Date:	May 21, 2010
	Original Closing Date for Applications:	May 07, 2013
	Current Closing Date for Applications:	May 07, 2013
	Archive Date:	Jun 07, 2013
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$3,000,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Description: Purpose. The objective of this solicitation is to stimulate research in the pre-clinical development and testing of novel therapeutic compounds aimed at slowing, halting, or reversing the progressive decline in cognitive function and modifying the behavioral symptoms in Alzheimer's disease (AD); or delaying the onset of or preventing AD, mild cognitive impairment (MCI), or age-related cognitive decline. This initiative is intended to stimulate activities focused on providing sufficient data to submit an Investigational New Drug (IND) application to the Food and Drug Administration to begin human clinical testing of potential new therapies. For this program neither mechanistic/basic studies nor clinical trials will be supported; only applications to develop a therapy will be accepted. Mechanism of Support. This FOA will utilize the U01 grant mechanism. Funds Available and Anticipated Number of Awards. NIA has set aside $3.0 M in total costs in FY2011 for applications submitted in response to this program announcement. However, because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/pa-10-205.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Analysis of Databases from Health Care Systems or Large Epidemiologic Studies to Evaluate Safety of ...; • T2 Translational Research: Research leading to new health care practices, community programs and pol...; • T1 Translational Research: Novel interventions for prevention and treatment of age-related condition...; • Social and Behavioral Research on the Elderly in Disasters (R03); • Network Infrastructure Support for Emerging Areas of Research in the Basic Biology of Aging (R24); • Technological Enhancements and Archiving for Surveys of the Elderly: SBIR (R43/44) Initiative; • Technological Enhancements and Archiving for Surveys of the Elderly: STTR (R41/42) Initiative; • Technology and Aging: NIA Small Business Technology Transfer Program Initiative (STTR [R41/R42]); • Technology and Aging: NIA Small Business Innovation Research Program Initiative (SBIR [R43/R44]); • ACUTE CORONARY SYNDROMES IN OLD AGE